Abstract
Neuroendocrine neoplasms arise from the gastrointestinal tract and can lead to carcinoid syndrome. Carcinoid heart disease affects more than half of these patients and is the initial presentation of carcinoid syndrome in up to 20 % of patients. Carcinoid heart disease typically leads to valve dysfunction, but in rare instances, carcinoid tumours can also metastasise to the endocardium and myocardium. Cardiovascular imaging plays an integral role in the diagnosis and prognosis of carcinoid heart disease. The use of multimodality imaging techniques including echocardiography, cardiac MRI, cardiovascular CT and positron emission tomography have allowed for a more comprehensive assessment of carcinoid heart disease. In this review, we discuss the features of carcinoid heart disease observed on multimodality imaging, indications for obtaining imaging studies and their role in carcinoid heart disease management.
Original language | English (US) |
---|---|
Article number | e001060 |
Journal | Open Heart |
Volume | 6 |
Issue number | 1 |
DOIs | |
State | Published - Jun 1 2019 |
Keywords
- cardiac remodelling
- echocardiography
- tricuspid valve disease
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
MD Anderson CCSG core facilities
- Clinical Trials Office